ES2125617T3 - Derivados de acidos aminosulfonicos, utilizacion de los mismos en la sintesis de pseudopeptidos y procedimiento para su preparacion. - Google Patents

Derivados de acidos aminosulfonicos, utilizacion de los mismos en la sintesis de pseudopeptidos y procedimiento para su preparacion.

Info

Publication number
ES2125617T3
ES2125617T3 ES95919441T ES95919441T ES2125617T3 ES 2125617 T3 ES2125617 T3 ES 2125617T3 ES 95919441 T ES95919441 T ES 95919441T ES 95919441 T ES95919441 T ES 95919441T ES 2125617 T3 ES2125617 T3 ES 2125617T3
Authority
ES
Spain
Prior art keywords
sub
synthesis
derivatives
preparation
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95919441T
Other languages
English (en)
Inventor
Cesare Gennari
Donatella Potenza
Barbara Salom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2125617T3 publication Critical patent/ES2125617T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/69—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a carbon skeleton substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

DERIVADOS DE ACIDOS SULFONICOS GAMMA-AMINO-ALFA-BETAINSATURADOS DE FORMULA (I), DONDE R SE ELIGE ENTRE HIDROGENO, FRAGMENTOS CORRESPONDIENTES A CADENAS LATERALES DE AMINOACIDOS NATURALES, SUSTITUIDOS O NO SUSTITUIDOS: CADENAS DE ALQUILO LINEALES, RAMIFICADOS O CICLICOS; CADENAS DE ARILALQUILO; GRUPOS ARILO O HETEROAROMATICOS; Y INDICA HIDROGENO, INCLUYENDO POSIBLES FORMAS SALINAS DE LA CORRESPONDIENTE AMINA; O CUALQUIER GRUPO PROTECTOR NORMALMENTE UTILIZADO PARA LA PROTECCION DEL GRUPO AMINO; X INDICA CL, OH, OCH{SUB,2}CH{SUB,3}, OCH{SUB,3}, ONBU{SUB,4}, NHCH{SUB,2}PH; PROCESO PARA LA PREPARACION DE LOS MISMOS Y SU UTILIZACION EN LA SINTESIS DE PSEUDOPEPTIDOS CARACTERIZADA POR LA PRESENCIA DE AL MENOS UN ENLACE DE TIPO SULFONAMIDA CONJUGADA CON UN DOBLE ENLACE.
ES95919441T 1994-05-17 1995-05-11 Derivados de acidos aminosulfonicos, utilizacion de los mismos en la sintesis de pseudopeptidos y procedimiento para su preparacion. Expired - Lifetime ES2125617T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940989A IT1269511B (it) 1994-05-17 1994-05-17 Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione

Publications (1)

Publication Number Publication Date
ES2125617T3 true ES2125617T3 (es) 1999-03-01

Family

ID=11368917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95919441T Expired - Lifetime ES2125617T3 (es) 1994-05-17 1995-05-11 Derivados de acidos aminosulfonicos, utilizacion de los mismos en la sintesis de pseudopeptidos y procedimiento para su preparacion.

Country Status (17)

Country Link
US (1) US5869725A (es)
EP (1) EP0759902B1 (es)
JP (1) JP4023554B2 (es)
KR (1) KR970703307A (es)
CN (1) CN1148847A (es)
AT (1) ATE174329T1 (es)
AU (1) AU691292B2 (es)
CA (1) CA2189896A1 (es)
DE (1) DE69506540T2 (es)
ES (1) ES2125617T3 (es)
FI (1) FI964582A0 (es)
HU (1) HUT76483A (es)
IT (1) IT1269511B (es)
NO (1) NO964861L (es)
NZ (1) NZ285763A (es)
PL (1) PL317258A1 (es)
WO (1) WO1995031433A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214799B1 (en) 1996-05-14 2001-04-10 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
US6020371A (en) * 1997-03-28 2000-02-01 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds compositions containing them and methods for their use
US6331554B1 (en) 1997-03-28 2001-12-18 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, compositions containing them, and methods for their use
US5962487A (en) * 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
CN1198838C (zh) 1998-04-30 2005-04-27 阿格罗尼制药公司 抗小rna病毒化合物及其制备方法和用途
JP2002516904A (ja) 1998-06-03 2002-06-11 ジーピーアイ ニル ホールディングス インコーポレイテッド Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド
US6358928B1 (en) 1999-11-22 2002-03-19 Enzyme Systems Products Peptidyl sulfonyl imidazolides as selective inhibitors of serine proteases
PA8507801A1 (es) 1999-12-03 2002-08-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PE20011277A1 (es) 2000-04-14 2002-01-07 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PL365470A1 (en) 2000-06-14 2005-01-10 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
JPWO2002074299A1 (ja) * 2000-12-27 2004-07-08 味の素株式会社 ＴＮＦα産生抑制剤

Also Published As

Publication number Publication date
EP0759902A1 (en) 1997-03-05
CA2189896A1 (en) 1995-11-23
ITMI940989A0 (it) 1994-05-17
FI964582A (fi) 1996-11-15
WO1995031433A1 (en) 1995-11-23
NZ285763A (en) 1997-10-24
AU691292B2 (en) 1998-05-14
ATE174329T1 (de) 1998-12-15
JPH10500123A (ja) 1998-01-06
US5869725A (en) 1999-02-09
IT1269511B (it) 1997-04-01
AU2526895A (en) 1995-12-05
MX9605426A (es) 1998-05-31
HUT76483A (en) 1997-09-29
HU9603128D0 (en) 1997-01-28
DE69506540T2 (de) 1999-06-02
EP0759902B1 (en) 1998-12-09
ITMI940989A1 (it) 1995-11-17
FI964582A0 (fi) 1996-11-15
KR970703307A (ko) 1997-07-03
JP4023554B2 (ja) 2007-12-19
NO964861L (no) 1997-01-16
PL317258A1 (en) 1997-04-01
NO964861D0 (no) 1996-11-15
DE69506540D1 (de) 1999-01-21
CN1148847A (zh) 1997-04-30

Similar Documents

Publication Publication Date Title
ES2125617T3 (es) Derivados de acidos aminosulfonicos, utilizacion de los mismos en la sintesis de pseudopeptidos y procedimiento para su preparacion.
PE52396A1 (es) Nuevo compuesto que puede mantener, aumentar o restaurar la sensibilidad de las celulas a los agentes terapeuticos o profilacticos
ES2064310T3 (es) Procedimiento para preparar compuestos de imidazopiridina.
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ATE103273T1 (de) Carbonsaeure- und sulfonsaeureamide.
AU533348B2 (en) Water soluble peptides
NO900581L (no) Kryss-bundete hydrogeler og deres anvendelse som saarforbindinger.
GB1495956A (en) Flame retardant polycarbonate composition
KR870010110A (ko) 반응성 방화 제제 및 그것의 제조방법
ES2057322T3 (es) Derivados de amida de aminoacido substituidos, su fabricacion y uso.
ES2170846T3 (es) Composiciones cosmeticas con filtros solares.
GB1392253A (en) Water-soluble reactive benzoxanthene and benzothioxanthene dyestuffs and process for preparing them
MY104941A (en) Process for the preparation of 4-demethox- ydaunomycinone, the aglycone of 4-demethoxy -daunorubicin.
ES513002A0 (es) Procedimiento para la obtencion de derivados de aminociclitol saturados.
ES2061478T3 (es) Derivados de teofilin-metil-ditiolano y teofilin-metil-ditianilo, un metodo para su preparacion, y composiciones farmaceuticas que los contienen.
ES2042875T3 (es) Procedimiento para el te\ido de cuero con pigmentos.
GB1446326A (en) Direct dyes
ES2145220T3 (es) Derivados de espiroftalimida policiclicos, proceso para su preparacion y su uso como fulgimidas.
AR024671A1 (es) Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos
FI965097A0 (fi) Substituoidut alkyylidiamiinijohdannaiset ja niiden käyttö takykiniini antagonisteina
MX173323B (es) Procedimiento para preparar colorantes triazoicos negros y producto obtenido
ES2103144T3 (es) 2-nitro p-fenilendiaminas azufradas en posicion 5, su procedimiento de preparacion, composiciones tintoriales que las contienen y su utilizacion en el tinte de las fibras queratinicas.
ES2061228T3 (es) Compuestos azoicos, procedimiento para su preparacion y utilizacion como colorantes.
ES2040293T3 (es) Compuestos disazoicos solubles en agua, procedimiento para su preparacion y su utilizacion como colorantes.
ES2038694T3 (es) Procedimiento para la preparacion de los derivados de la 8-azaxantina alquilaminoalquil o heterociclilalquil sustituida en el anillo de triazol, asi como sales de la misma aceptables en la terapeutica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 759902

Country of ref document: ES